Bando, H., Yoshino, T., Tsuchihara, K., Ogasawara, N., Fuse, N., Kojima, T., . . . Ohtsu, A. (2011). KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab. Nature Publishing Group.
Chicago Style CitationBando, H., et al. KRAS Mutations Detected By the Amplification Refractory Mutation System–Scorpion Assays Strongly Correlate With Therapeutic Effect of Cetuximab. Nature Publishing Group, 2011.
Cita MLABando, H., et al. KRAS Mutations Detected By the Amplification Refractory Mutation System–Scorpion Assays Strongly Correlate With Therapeutic Effect of Cetuximab. Nature Publishing Group, 2011.
Atenció: Aquestes cites poden no estar 100% correctes.